[ Price : $8.95]
CeleCor Therapeutics says it has submitted an NDA for Disaggpro (zalunfiban), an investigational treatment for ST-segment elevatio...[ Price : $8.95]
The FY2025 FDA Report on the State of Pharmaceutical Quality shows increased quality assurance inspections over FY 2024.[ Price : $8.95]
A newly published commentary in the journal Stem Cell Research & Therapy says FDAs efforts to reduce reliance on animal testing is...[ Price : $8.95]
The Trump Administration considers White House health policy adviser Heidi Overton as a leading candidate to become the next FDA c...[ Price : $8.95]
JAMA publishes a controversial Covid-19 vaccine effectiveness study, which was previously blocked from publication in a Centers fo...[ Price : $8.95]
Eight Hyman, Phelps & McNamara attorneys analyze a House Appropriations Committee report that explains its rationale and expectati...[ Price : $8.95]
The Federal Trade Commission files an amicus brief supporting plaintiffs in an antitrust lawsuit accusing Johnson & Johnson of unl...[ Price : $8.95]
A new CDER Office of New Drugs webinar discusses the development and use of OND Custom Medical Queries to identify potential safet...